The family of Henrietta Lacks is suing rare disease drug developer Ultragenyx over its use of technology built from her cells, which were taken without her knowledge or consent in 1951 and immortalized into a cell line that’s been widely used in biomedical research since.
Registered office
11 Lyons Walk
Shaftesbury
Dorset
SP7 8JF
office@icr-global.org